HEADER TRANSCRIPTION 14-SEP-12 2LY9 TITLE SOLUTION NMR STRUCTURE OF HOMEOBOX 2 DOMAIN FROM HUMAN ZHX1 REPRESSOR, TITLE 2 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET HR7907F COMPND MOL_ID: 1; COMPND 2 MOLECULE: ZINC FINGERS AND HOMEOBOXES PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: DNA BINDING HOMEOBOX 2 RESIDUES 462-532; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ZHX1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PMGK; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET15AVI6HT_NESG KEYWDS STRUCTURAL GENOMICS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG), KEYWDS 2 PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, TRANSCRIPTION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR X.XU,A.ELETSKY,J.L.MILLS,S.V.S.R.K.PULAVARTI,D.LEE,E.KOHAN,H.JANJUA, AUTHOR 2 R.XIAO,T.B.ACTON,J.K.EVERETT,G.T.MONTELIONE,T.SZYPERSKI,NORTHEAST AUTHOR 3 STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 1 14-NOV-12 2LY9 0 JRNL AUTH X.XU,A.ELETSKY,J.L.MILLS,S.V.S.R.K.PULAVARTI,D.LEE,E.KOHAN, JRNL AUTH 2 H.JANJUA,R.XIAO,T.B.ACTON,J.K.EVERETT,G.T.MONTELIONE, JRNL AUTH 3 T.SZYPERSKI JRNL TITL SOLUTION NMR STRUCTURE OF HOMEOBOX 2 DOMAIN FROM HUMAN ZHX1 JRNL TITL 2 REPRESSOR, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) JRNL TITL 3 TARGET HR7907F JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 3.0, AS-DP 1.0 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), HUANG, REMARK 3 TEJERO, POWERS AND MONTELIONE (AS-DP) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE DETERMINATION WAS PERFORMED REMARK 3 BY RUNNING CYANA AND ASDP IN PARALLEL USING NOE-BASED CONSTRAINTS REMARK 3 AND PHI AND PSI DIHEDRAL ANGLE CONSTRAINTS FROM TALOS+. CONSENSUS REMARK 3 PEAK ASSIGNMENTS WERE SELECTED AND USED IN ITERATIVE REFINEMENT REMARK 3 WITH CYANA. THE 20 CONFORMERS OUT OF 100 WITH THE LOWEST TARGET REMARK 3 FUNCTION WERE FURTHER REFINED BY SIMULATED ANNEALING IN EXPLICIT REMARK 3 WATER BATH USING THE PROGRAM CNS WITH PARAM19 FORCE FIELD NMR REMARK 3 ENSEMBLE INFORMATION REMARK 4 REMARK 4 2LY9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-SEP-12. REMARK 100 THE RCSB ID CODE IS RCSB102982. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.4 MM [U-100% 13C; U-100% 15N] REMARK 210 HR7907F, 0.02 % SODIUM AZIDE, 10 REMARK 210 MM DTT, 5 MM CALCIUM CHLORIDE, REMARK 210 100 MM SODIUM CHLORIDE, 1 X REMARK 210 PROTEINASE INHIBITORS, 20 MM MES, REMARK 210 50 UM DSS, 90% H2O/10% D2O; 0.3 REMARK 210 MM [5% 13C; U-100% 15N] HR7907F, REMARK 210 0.02 % SODIUM AZIDE, 10 MM DTT, 5 REMARK 210 MM CALCIUM CHLORIDE, 100 MM REMARK 210 SODIUM CHLORIDE, 1 X PROTEINASE REMARK 210 INHIBITORS, 20 MM MES, 50 UM DSS, REMARK 210 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCO; (4,3)D GFT CABCA(CO)NHN; REMARK 210 (4,3)D GFT HNNCABCA; (4,3)D GFT REMARK 210 HCCH-COSY ALIPAHTIC; 3D (H)CCH- REMARK 210 TOCSY ALIPHATIC; 3D 13C/15N- REMARK 210 EDITED NOESY; (4,3)D GFT REMARK 210 HABCAB(CO)NH; 3D (H)CCH-COSY REMARK 210 AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CARA 1.8.4, CYANA 3.0, AS-DP REMARK 210 1.0, AUTOASSIGN 2.3.0, XEASY, REMARK 210 VNMRJ, TALOS+, PSVS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 2 -46.19 -130.79 REMARK 500 1 SER A 6 12.13 -150.74 REMARK 500 1 ARG A 10 19.29 59.34 REMARK 500 1 SER A 66 -60.53 72.89 REMARK 500 1 ASN A 67 -70.56 -84.31 REMARK 500 2 MET A 3 103.40 64.68 REMARK 500 2 ASP A 5 87.23 -67.34 REMARK 500 2 ALA A 11 -159.57 58.16 REMARK 500 2 LYS A 13 99.41 -69.45 REMARK 500 2 CYS A 69 -175.73 66.63 REMARK 500 2 LEU A 70 -70.41 75.39 REMARK 500 3 ASP A 5 134.10 71.75 REMARK 500 3 ALA A 11 -73.22 72.62 REMARK 500 3 THR A 43 -61.62 -90.65 REMARK 500 3 SER A 66 172.62 65.05 REMARK 500 3 ASN A 73 97.61 -66.43 REMARK 500 4 PRO A 4 105.91 -53.39 REMARK 500 4 ILE A 9 99.56 -63.49 REMARK 500 4 ARG A 10 -72.72 61.54 REMARK 500 4 ALA A 11 92.38 -67.97 REMARK 500 4 ASN A 63 45.66 -107.08 REMARK 500 5 MET A 3 151.28 71.46 REMARK 500 5 PRO A 4 92.59 -56.02 REMARK 500 5 PHE A 7 95.35 -62.20 REMARK 500 5 ASN A 67 -154.28 55.79 REMARK 500 5 LEU A 70 -66.92 -154.80 REMARK 500 6 HIS A 2 16.06 -158.53 REMARK 500 6 MET A 3 86.63 -153.23 REMARK 500 6 SER A 6 -79.89 -117.41 REMARK 500 6 HIS A 32 -79.35 -62.68 REMARK 500 6 ASP A 33 -52.15 -179.73 REMARK 500 6 CYS A 69 86.85 67.38 REMARK 500 7 ASP A 5 32.19 -84.89 REMARK 500 7 PHE A 7 90.06 62.41 REMARK 500 7 ARG A 10 -41.76 -156.09 REMARK 500 7 LYS A 13 177.25 66.66 REMARK 500 7 HIS A 32 -70.95 -68.73 REMARK 500 7 ASP A 33 -43.23 -159.32 REMARK 500 8 PHE A 7 -53.18 -121.61 REMARK 500 8 ARG A 10 89.75 64.17 REMARK 500 8 ASN A 28 100.44 -164.85 REMARK 500 8 HIS A 32 -71.32 -79.99 REMARK 500 8 ASP A 33 -54.95 -155.40 REMARK 500 8 GLN A 61 -60.69 -91.93 REMARK 500 8 LYS A 65 -82.47 -86.85 REMARK 500 8 SER A 66 -67.06 -178.32 REMARK 500 8 ASN A 67 103.44 59.05 REMARK 500 8 LEU A 70 43.33 -83.20 REMARK 500 9 ASP A 5 -76.45 -148.49 REMARK 500 9 SER A 6 -65.41 68.52 REMARK 500 REMARK 500 THIS ENTRY HAS 122 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: NESG-HR7907F RELATED DB: TARGETTRACK REMARK 900 RELATED ID: 18714 RELATED DB: BMRB DBREF 2LY9 A 4 74 UNP Q9UKY1 ZHX1_HUMAN 462 532 SEQADV 2LY9 SER A 1 UNP Q9UKY1 EXPRESSION TAG SEQADV 2LY9 HIS A 2 UNP Q9UKY1 EXPRESSION TAG SEQADV 2LY9 MET A 3 UNP Q9UKY1 EXPRESSION TAG SEQRES 1 A 74 SER HIS MET PRO ASP SER PHE GLY ILE ARG ALA LYS LYS SEQRES 2 A 74 THR LYS GLU GLN LEU ALA GLU LEU LYS VAL SER TYR LEU SEQRES 3 A 74 LYS ASN GLN PHE PRO HIS ASP SER GLU ILE ILE ARG LEU SEQRES 4 A 74 MET LYS ILE THR GLY LEU THR LYS GLY GLU ILE LYS LYS SEQRES 5 A 74 TRP PHE SER ASP THR ARG TYR ASN GLN ARG ASN SER LYS SEQRES 6 A 74 SER ASN GLN CYS LEU HIS LEU ASN ASN HELIX 1 1 THR A 14 ASN A 28 1 15 HELIX 2 2 HIS A 32 GLY A 44 1 13 HELIX 3 3 THR A 46 GLN A 61 1 16 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 164 0 0 3 0 0 0 6 0 0 0 6 END